ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
61 263,34
0,76%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Paragon 28 Inc (FNA)

  7. Paragon 28 Inc (FNA) Actualités

FNA

Paragon 28 (FNA)

Paragon 28 Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:FNA
DateHeureSourceTitreSymboleSociété
08/05/202422h05Business WireParagon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue GuidanceNYSE:FNAParagon 28 Inc
08/05/202422h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:FNAParagon 28 Inc
08/05/202422h01Edgar (US Regulatory)Form 8-K - Current reportNYSE:FNAParagon 28 Inc
02/05/202422h05Business WireParagon 28 to Present at the Bank of America Securities 2024 Healthcare ConferenceNYSE:FNAParagon 28 Inc
04/04/202414h01Business WireParagon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024NYSE:FNAParagon 28 Inc
28/03/202421h05Business WireParagon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair SystemNYSE:FNAParagon 28 Inc
08/03/202423h19Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:FNAParagon 28 Inc
02/03/202401h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:FNAParagon 28 Inc
01/03/202422h09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:FNAParagon 28 Inc
29/02/202422h05Business WireParagon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue GuidanceNYSE:FNAParagon 28 Inc
29/02/202422h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:FNAParagon 28 Inc
14/02/202421h29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:FNAParagon 28 Inc
12/02/202417h36Business WireParagon 28 to Present at the CG 2024 Musculoskeletal ConferenceNYSE:FNAParagon 28 Inc
06/02/202422h05Business WireParagon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024NYSE:FNAParagon 28 Inc
01/02/202414h00Business WireParagon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with BunionsNYSE:FNAParagon 28 Inc
30/01/202422h43Business WireParagon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle ProceduresNYSE:FNAParagon 28 Inc
26/01/202414h00Business WireParagon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer ProceduresNYSE:FNAParagon 28 Inc
17/01/202414h00Business WireParagon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion ProceduresNYSE:FNAParagon 28 Inc
08/01/202415h00Business WireParagon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023NYSE:FNAParagon 28 Inc
05/01/202414h00Business WireParagon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ TapeNYSE:FNAParagon 28 Inc
19/12/202322h05Business WireParagon 28 to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:FNAParagon 28 Inc
14/11/202322h05Business WireParagon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics PortfolioNYSE:FNAParagon 28 Inc
14/11/202314h00Business WireParagon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple OfferingNYSE:FNAParagon 28 Inc
13/11/202322h05Business WireParagon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training ProgramNYSE:FNAParagon 28 Inc
07/11/202322h05Business WireParagon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit FacilityNYSE:FNAParagon 28 Inc
07/11/202322h05Business WireParagon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue GuidanceNYSE:FNAParagon 28 Inc
03/11/202313h00Business WireParagon 28 to Present at Upcoming Investor ConferencesNYSE:FNAParagon 28 Inc
17/10/202322h05Business WireParagon 28 To Report Third Quarter Financial Results on November 7, 2023NYSE:FNAParagon 28 Inc
11/09/202313h00Business WireParagon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement SystemNYSE:FNAParagon 28 Inc
28/08/202322h05Business WireParagon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNYSE:FNAParagon 28 Inc
 Showing the most relevant articles for your search:NYSE:FNA

Dernières Valeurs Consultées

LSE
M066
Me_ukx & S_m066
NYSE
BUD
Anheuser Busch Inbev SA NV
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés